Sandbox Reserved 1123: Difference between revisions

Revision as of 12:54, 29 January 2016 view source Loïc Duffet (talk \| contribs) 118 edits No edit summary ← Older edit		Revision as of 12:55, 29 January 2016 view source Loïc Duffet (talk \| contribs) 118 edits No edit summary Newer edit →
Line 73:		Line 73:

	This approach is interesting because, based on structural information, we are able to build such ligands using drug design. However, we are still far away from the "miraculous HIV drug", because the pathway from design to approved drug is not an easy way at all.		This approach is interesting because, based on structural information, we are able to build such ligands using drug design. However, we are still far away from the "miraculous HIV drug", because the pathway from design to approved drug is not an easy way at all.

Navigation menu